Stuart Essig - 14 Aug 2025 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Aug 2025, 16:43:39 UTC
Prior SEC filing
02 Jul 2025
Next SEC filing
03 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lesha Shinn; Attorney-in-Fact

Key filing fact

Stuart Essig filed Form 4 for INTEGRA LIFESCIENCES HOLDINGS CORP (IART) on 18 Aug 2025.

Key facts

  • This page summarizes Stuart Essig's Form 4 filing for INTEGRA LIFESCIENCES HOLDINGS CORP (IART).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Aug 2025, 16:43.

Change

  • Previous filing in this sequence was filed on 02 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001187574 Primary reporting owner

ESSIG STUART

Relationship
Director
Address
1100 CAMPUS ROAD, PRINCETON
Signature
/s/ Lesha Shinn; Attorney-in-Fact
Signature date
18 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IART transaction

Common Stock

Other

Transaction value
$2,724,000
Shares
-200,000
Change %
-15%
Price
$13.62
Shares after
1,152,236
Date
14 Aug 2025
Ownership
Direct
Footnotes
F1, F2, F3
IART transaction

Common Stock

Other

Transaction value
$2,724,000
Shares
+200,000
Change %
Price
$13.62
Shares after
200,000
Date
14 Aug 2025
Ownership
By Grantor Trust
IART holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
219,920
Date
14 Aug 2025
Ownership
By GRAT E
Footnotes
F2
IART holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
14 Aug 2025
Ownership
By GRAT F
Footnotes
F3
IART holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
213,115
Date
14 Aug 2025
Ownership
By Family Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On August 14, 2025, the reporting person transferred 200,000 shares of common stock to a grantor trust for which his spouse is the trustee. In exchange for the shares, the trust transferred assets to the reporting person with a fair market value equal to the transferred shares. The transfer of shares to the trust resulted in a decrease in the number of shares the reporting person beneficially owns directly and a corresponding increase in the number of shares the reporting person beneficially owns indirectly through the trust.

Footnote F2

On August 8, 2025, in accordance with the provisions of a grantor retained annuity trust ("GRAT E"), 180,080 shares of common stock were distributed from GRAT E to the reporting person as an annuity payment in accordance with the terms of GRAT E.

Footnote F3

On August 8, 2025, in accordance with the provisions of a grantor retained annuity trust ("GRAT F"), 500,000 shares of common stock were distributed from GRAT F to the reporting person as an annuity payment in accordance with the terms of GRAT F. The amount of shares available for distribution were insufficient to satisfy the full amount of the annuity payment obligation and so GRAT F was terminated, in accordance with the terms of GRAT F, following the completion of the foregoing distribution.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .